Cybin Inc
(NY:
CYBN
)
0.2646
-0.0001 (-0.04%)
Official Closing Price
Updated: 6:30 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cybin Inc
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
October 23, 2021
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last.
Via
Talk Markets
Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma
October 19, 2021
Ronan Levy, co-founder and executive chairman of Field Trip Ltd (NASDAQ: FTRP), a company developing a network of psychedelics-assisted therapy clinics; Doug Drysdale, CEO,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
This Psychedelics Stock Could Grow 300% In One Year
August 26, 2021
Cantor Fitzgerald initiated coverage of Cybin (NYSE:
Via
Benzinga
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021
October 15, 2021
Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month.
Via
Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
October 01, 2021
This article by Jason Najum was originally published on
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ:
Via
Benzinga
Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference
September 30, 2021
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. ...
Via
Benzinga
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio?
September 21, 2021
We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses.
Via
Talk Markets
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
September 20, 2021
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
38 Stocks Moving In Thursday's Mid-Day Session
September 16, 2021
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS...
Via
Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
Marijuana Vs. Psychedelic Drug Stocks: Which Out-Performed Last Week?
September 06, 2021
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 8 constituents in each of two sub-categories, let's see which out-performed last week.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Buying Cybin Stock Right Now Could Be a Brilliant Move
September 02, 2021
You'll need to be prepared for a long holding period and a hearty helping of risk.
Via
The Motley Fool
Topics
Law Enforcement
Exposures
Legal
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
48 Biggest Movers From Yesterday
August 31, 2021
Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,...
Via
Benzinga
Exposures
Product Safety
35 Stocks Moving In Monday's Mid-Day Session
August 30, 2021
Gainers Globalstar, Inc. (NYSE: GSAT) shares climbed 43.6% to $2.0535. GSAT shares traded higher following a note sent out by popular Apple Inc. (NASDAQ: AAPL) analyst Ming...
Via
Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
Magic Mushroom Drug Stock Performances YTD
August 29, 2021
Of the 35 companies involved in clinical stage research of psychedelic substances, 20 are researching the benefits of psilocybin, the primary psychoactive ingredient in “magic mushrooms”.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
August 26, 2021
Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE:
Via
Benzinga
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
August 19, 2021
Cybin (NEO: CYBN) (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed two additional international patent applications; these...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent
August 10, 2021
Cybin Debuts On The NYSE Last week, Cybin (NYSE:CYBN...
Via
Benzinga
Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know
August 05, 2021
Cybin (NYSE:CYBN), a biotech company in the psychedelics spa...
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.